UBE2C and hepatocellular carcinoma: In previous studies, ubiquitin-conjugating enzyme E2C (UBE2C), pituitary tumor transforming gene 1 (PTTG1), topoisomerase II alpha (TOP2A), and secreted phosphoprotein 1 (SPP1) have been recognized as oncogenes promoting the progression of HCC.